Zolpidem Tartrate
Product Images NDC 40032-762

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 40032-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novel Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (8803cf1f 08be 409e B37e C83a0313fcbc 01)

FDA Label Image

A (8803cf1f 08be 409e B37e C83a0313fcbc 02)

FDA Label Image

B (8803cf1f 08be 409e B37e C83a0313fcbc 03)

FDA Label Image

C (8803cf1f 08be 409e B37e C83a0313fcbc 04)

The text appears to be instructions for taking a specific medication called Zolpidem Tartrate Sublingual Tablet. It provides information on the dosage and timing of the medication, and includes instructions for when to take the medication depending on when the patient needs to wake up. The text also includes a diagram, labeled "Figure C", which is not visible in the output.*

FDA Label Image

D (8803cf1f 08be 409e B37e C83a0313fcbc 05)

FDA Label Image

E (8803cf1f 08be 409e B37e C83a0313fcbc 06)

FDA Label Image

F (8803cf1f 08be 409e B37e C83a0313fcbc 07)

FDA Label Image

G (8803cf1f 08be 409e B37e C83a0313fcbc 08)

FDA Label Image

1.75-car-1 (8803cf1f 08be 409e B37e C83a0313fcbc 09)

This is a description of Zolpidem Tartrate Pouches, which contain sublingual tablets for administration. The contents include 30 unit-dose pouches, each containing one sublingual tablet in a blister. The usual adult dosage is specified in the accompanying prescribing literature, and the medication should not be swallowed whole. The package also includes medication guides and dosing time tools. This product is manufactured by Novel Laboratories, Inc. and is for sublingual administration only.*

FDA Label Image

1.75-car-2 (8803cf1f 08be 409e B37e C83a0313fcbc 10)

FDA Label Image

3.5-car-1 (8803cf1f 08be 409e B37e C83a0313fcbc 11)

This is a medication package containing 30 unit-dose pouches of Zolpidem Tartrate in sublingual tablet forms, manufactured by Novel Laboratories. The pouches come with one sublingual tablet inside the blister and two dosing time tools. The medication guide needs to be read before use, and the tablet should not be swallowed whole. The adult dosage is to be seen in the prescribing literature. The package has a unique NDC number of 40032-761-30.*

FDA Label Image

3.5-car-2 (8803cf1f 08be 409e B37e C83a0313fcbc 12)

Zolpidem Tartrate @ Pohes is a sublingual tablet with each containing 3.5 mg of zolpidem tartrate. It is recommended to store it at a temperature of 20°C to 25°C and protect it from moisture. The tablets are not to be swallowed and the medication guide should be read before use. The lot number is provided as 3 40032776130. The usual adult dosage information is available in the prescribing literature. Pharmacies are advised to provide patients with the medication guide and dosing time tool.*

FDA Label Image

1.75-pouch (8803cf1f 08be 409e B37e C83a0313fcbc 13)

This is a medication label for Zolpidem Tartrate Sublingual Tablet that is administered by placing the tablet under the tongue. The label warns not to swallow the tablet whole and advises taking it only if there are at least 8 hours of bedtime left. It also provides instructions on storing the tablet between 20-25°C (68-77°F) and includes contact information for the manufacturer. The text mentions a broken or missing "I iste s 1" without providing context or explanation, and includes errors.*

FDA Label Image

3.5-pouch (8803cf1f 08be 409e B37e C83a0313fcbc 14)

This is a medication package for Zolpidem Tartrate sublingual tablets. The instructions indicate that the tablet should be placed under the tongue and left to dissolve, and should not be swallowed whole. It is recommended to only take the tablet when there is at least 8 hours of bedtime remaining. The package also includes storage instructions and a caution to protect the tablets from moisture. There is some random gibberish and incomplete sentences throughout the text.*

FDA Label Image

1.75-blister (8803cf1f 08be 409e B37e C83a0313fcbc 15)

This is a medication package of Zolpidem Tartrate with NDC code 40032-762-01, manufactured by Novel Laboratories, Inc., located in Somerset, NJ 08873. It provides instructions on how to open the blister with scissors at the dotted line and take the tablet out. It also includes the lot number X00000X with an expiration date of 00/0000.*

FDA Label Image

3.5-blister (8803cf1f 08be 409e B37e C83a0313fcbc 16)

This appears to be information relating to a medication called Zolpidem Tartrate, with a National Drug Code identifier of 40032-761-01. The medication was manufactured by Novel Laboratories, Inc. located in Somerset, NJ. The instructions indicate that one should cut the blister packaging with scissors at the dotted line to access the tablet. Additionally, there is a lot number and expiration date included.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.